Founded by world-class geneticists, machine-learning and bioinformaticians from Stanford, Harvard, and MIT, and funded by Sequoia Capital, SV Bio is building the worlds’ first clinical-grade genomic interpretation platform. As the cost of genetic sequencing drops below $1000 for an entire human genome, the challenge now facing us is how to accurately decode and interpret this explosion of data in a meaningful way that improves patient outcomes and reduces the cost of healthcare. We, at SVBio, are building a team that is passionate about this vision.
The challenges that we face span multiple disciplines, ranging from machine-learning to robust distributed infrastructures operating on extensive biological and medical knowledge. We are looking for the most talented engineers and research scientists to join us at this exciting early stage. If you are interested in joining a small team of exceptional scientists and engineers working to solve an incredibly complex and important problem (computational interpretation of the human genome to improve patient care) then we encourage you to apply to join us.